MedTrace Logo

Liver Function Test Abnormalities in COVID-19

NCT04763395 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2021-09-24

No results posted yet for this study

Summary

With the increasing number of COVID-19 infected patients, several studies reported that the liver is the most frequently affected organ after lung damage. The percentage of infected patients who had abnormal levels of transaminases (alanine aminotransferase (ALT) and aspartate aminotransferase (AST)) was about 14.8-53.1%. The elevation in serum bilirubin was mostly mild.

Aims of work:

* To study liver function tests abnormalities in Egyptian patients who infected with COVID19
* To evaluate if liver function test abnormalities are related to the severity of the Covid19.

Conditions

  • Liver Function Tests Abnormalities

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Asmaa Mahmoud, lecturer · Sohag University

  • Mustafa Younis, lecturer · Sohag University

  • Mahmoud Mahmoud, lecturer · Sohag University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-29
Primary Completion
2021-02-20
Completion
2021-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04763395 on ClinicalTrials.gov